Cite Filings / KROS / 0002012383-26-002890

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Keros Therapeutics, Inc. Filed 2026-07-29 Acc 0002012383-26-002890

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-08-03 8-K Regulation FD disclosure
2026-08-03 10-Q Quarterly Report
2026-08-03 8-K Results of operations
2026-07-30 8-K Regulation FD disclosure
2026-07-29 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…